Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

International Journal of Antimicrobial Agents

Volumn 55, Issue 3, 2020, Pages

  Lai, Chih Cheng ^a   Shih, Tzu Ping ^a   Ko, Wen Chien ^b   Tang, Hung Jen ^c   Hsueh, Po Ren ^d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2019 nCoV; China; COVID 19; Epidemic; Remdesivir; SARS CoV 2

Indexed keywords

3CLPRO INHIBITOR; ALCOHOL; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; ARBIDOL; BENZALKONIUM CHLORIDE; CHINESE DRUG; CHLORHEXIDINE GLUCONATE; CHLOROQUINE; CORTICOSTEROID; DISINFECTANT AGENT; GANCICLOVIR; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; IMMUNOGLOBULIN; LAMIVUDINE; LIANHUA QINGWEN; LOPINAVIR PLUS RITONAVIR; NUCLEOSIDE ANALOG; OSELTAMIVIR; PEPTIDE DERIVATIVE; PROTEINASE INHIBITOR; REMDESIVIR; SHUFENG JIEDU; SIALIDASE INHIBITOR; STEROID; TENOFOVIR DISOPROXIL; UNCLASSIFIED DRUG;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIVIRAL ACTIVITY; ARTIFICIAL VENTILATION; ASYMPTOMATIC INFECTION; BASIC REPRODUCTION NUMBER; CHINA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS RENAL REPLACEMENT THERAPY; CORONAVIRINAE; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; COUGHING; DRUG EFFICACY; DRUG RESPONSE; EPIDEMIC; EXTRACORPOREAL OXYGENATION; FEVER; HUMAN; HYPOXEMIA; INCIDENCE; INCUBATION TIME; INFECTION CONTROL; INFECTION PREVENTION; INTENSIVE CARE UNIT; MIXED INFECTION; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECONDARY INFECTION; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; SHOCK; TREATMENT OUTCOME; VIRUS INACTIVATION; VIRUS PNEUMONIA; VIRUS TRANSMISSION; BETACORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; WORLD HEALTH ORGANIZATION;

BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; DISEASE OUTBREAKS; HUMANS; PNEUMONIA, VIRAL; SEVERE ACUTE RESPIRATORY SYNDROME; WORLD HEALTH ORGANIZATION;

EID: 85080064519     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2020.105924     Document Type: Review

References (48)

1. Lu, H., Stratton, C.W., Tang, Y.W., Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle. J Med Virol, 2020 Jan 16, 10.1002/jmv.25678 [Epub ahead of print].
2. Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med, 2020 Jan 29, 10.1056/NEJMoa2001316 [Epub ahead of print].
3. Gorbalenya, A.E., Baker, S.C., Baric, R.S., de Groot, R.J., Drosten, C., Gulyaeva, A.A., et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the Coronavirus Study Group. bioRxiv, 2020 Feb 11, 10.1101/2020.02.07.937862.
4. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (2020), 507–513, 10.1016/S0140-6736(20)30211-7.
5. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395 (2020), 497–506, 10.1016/S0140-6736(20)30183-5.
6. Wang, C., Horby, P.W., Hayden, F.G., Gao, G.F., A novel coronavirus outbreak of global health concern. Lancet 395 (2020), 470–473, 10.1016/S0140-6736(20)30185-9.
7. Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. First case of 2019 novel coronavirus in the United States. N Engl J Med, 2020 Jan 31, 10.1056/NEJMoa2001191 [Epub ahead of print].
8. Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020 Feb 7, 10.1001/jama.2020.1585 [Epub ahead of print].
9. Chang, D., Lin, M., Wei, L., Xie, L., Zhu, G., Dela Cruz, C.S., et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA, 2020 Feb 7, 10.1001/jama.2020.1623 [Epub ahead of print].
10. Carlos, W.G., Dela Cruz, C.S., Cao, B., Pasnick, S., Jamil, S., Novel Wuhan (2019-nCoV) coronavirus. Am J Respir Crit Care Med 201 (2020), P7–P8, 10.1164/rccm.2014P7.
11. Zhao, S., Lin, Q., Ran, J., Musa, S.S., Yang, G., Wang, W., et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92 (2020), 214–217, 10.1016/j.ijid.2020.01.050.
12. Biscayart, C., Angeleri, P., Lloveras, S., Chaves, T., Schlagenhauf, P., Rodriguez-Morales, A.J., The next big threat to global health? 2019 novel coronavirus (2019-nCoV): What advice can we give to travellers? — Interim recommendations January 2020, from the Latin-American Society for Travel Medicine (SLAMVI). Travel Med Infect Dis, 2020, 101567, 10.1016/j.tmaid.2020.101567.
13. Munster, V.J., Koopmans, M., van Doremalen, N., van Riel, D., de Wit, E., A novel coronavirus emerging in China—key questions for impact assessment. N Engl J Med, 2020 Jan 24, 10.1056/NEJMp2000929 [Epub ahead of print].
14. Yoo, J.H., The fight against the 2019-nCoV outbreak: an arduous march has just begun. J Korean Med Sci, 35, 2020, e56, 10.3346/jkms.2020.35.e56.
15. Lee, K.H., Yoo, S.G., Cho, Y., Kwon, D.E., La, Y., Han, S.H., et al. Characteristics of community-acquired respiratory viruses infections except seasonal influenza in transplant recipients and non-transplant critically ill patients. J Microbiol Immunol Infect, 2019 Jun 19, 10.1016/j.jmii.2019.05.007 [Epub ahead of print].
16. Chou, C.C., Shen, C.F., Chen, S.J., Chen, H.M., Wang, Y.C., Chang, W.S., et al. Recommendations and guidelines for the treatment of pneumonia in Taiwan. J Microbiol Immunol Infect 52 (2019), 172–199, 10.1016/j.jmii.2018.11.004.
17. Lee, J.Y., Yang, P.C., Chang, C., Lin, I.T., Ko, W.C., Cia, C.T., Community-acquired adenoviral and pneumococcal pneumonia complicated by pulmonary aspergillosis in an immunocompetent adult. J Microbiol Immunol Infect 52 (2019), 838–839, 10.1016/j.jmii.2019.05.014.
18. Su, I.C., Lee, K.L., Liu, H.Y., Chuang, H.C., Chen, L.Y., Lee, Y.J., Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient. J Microbiol Immunol Infect 52 (2019), 365–366, 10.1016/j.jmii.2018.05.007.
19. Lee, S.H., Ruan, S.Y., Pan, S.C., Lee, T.F., Chien, J.Y., Hsueh, P.R., Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower respiratory tract specimens of adult patients in intensive care units. J Microbiol Immunol Infect 52 (2019), 920–928, 10.1016/j.jmii.2019.10.009.
20. Hung, H.M., Yang, S.L., Chen, C.J., Chiu, C.H., Kuo, C.Y., Huang, K.A., et al. Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan. J Microbiol Immunol Infect 52 (2019), 233–241, 10.1016/j.jmii.2018.08.009.
21. Lin, G.L., Lu, C.Y., Chen, J.M., Lee, P.I., Ho, S.Y., Weng, K.C., et al. Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014. J Microbiol Immunol Infect 52 (2019), 215–224, 10.1016/j.jmii.2018.07.005.
22. Chan, J.F., Kok, K.H., Zhu, Z., Chu, H., To, K.K., Yuan, S., et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 9 (2020), 221–236, 10.1080/22221751.2020.1719902.
23. Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020 Jan 30, 10.1016/S0140-6736(20)30251-8 [Epub ahead of print].
24. Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 2020 Jan 24, 10.1056/NEJMoa2001017 [Epub ahead of print].
25. Jiang, S., Du, L., Shi, Z., An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies. Emerg Microbes Infect 9 (2020), 275–277, 10.1080/22221751.2020.1723441.
26. Ren, L.L., Wang, Y.M., Wu, Z.Q., Xiang, Z.C., Guo, L., Xu, T., et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J (Engl), 2020 Jan 30, 10.1097/CM9.0000000000000722 [Epub ahead of print].
27. Chen, L., Liu, W., Zhang, Q., Xu, K., Ye, G., Wu, W., et al. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak. Emerg Microbes Infect 9 (2020), 313–319, 10.1080/22221751.2020.1725399.
28. Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020 Feb 3, 10.1038/s41586-020-2012-7 [Epub ahead of print].
29. Wu, J.T., Leung, K., Leung, G.M., Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet, 2020 Jan 31, 10.1016/S0140-6736(20)30260-9 [Epub ahead of print].
30. Backer, J.A., Klinkenberg, D., Wallinga, J., Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China, 20–28 January 2020. Euro Surveill, 25, 2020, 10.2807/1560-7917.ES.2020.25.5.2000062.
31. Chen, Z.M., Fu, J.F., Shu, Q., Chen, Y.H., Hua, C.Z., Li, F.B., et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World J Pediatr, 2020 Feb 5, 10.1007/s12519-020-00345-5 [Epub ahead of print].
32. Ryu, S., Chun, B.C., Epidemiological characteristics of 2019 novel coronavirus: an interim review. Epidemiol Health, 42, 2020, e2020006, 10.4178/epih.e2020006.
33. Chung, M., Bernheim, A., Mei, X., Zhang, N., Huang, M., Zeng, X., et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology, 2020 Feb 4, 10.1148/radiol.2020200230 [Epub ahead of print].
34. Kanne, J.P., Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology, 2020 Feb 4, 10.1148/radiol.2020200241 [Epub ahead of print].
35. Song, F., Shi, N., Shan, F., Zhang, Z., Shen, J., Lu, H., et al. Emerging coronavirus 2019-nCoV pneumonia. Radiology, 2020 Feb 6, 10.1148/radiol.2020200274 [Epub ahead of print].
36. Lu, H., Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends, 2020 Jan 28, 10.5582/bst.2020.01020 [Epub ahead of print].
37. Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res, 2020 Feb 4, 10.1038/s41422-020-0282-0 [Epub ahead of print].
38. Liu, W., Morse, J.S., Lalonde, T., Xu, S., Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. Chembiochem, 2020 Feb 5, 10.1002/cbic.202000047 [Epub ahead of print].
39. Rolain, J.M., Colson, P., Raoult, D., Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 30 (2007), 297–308, 10.1016/j.ijantimicag.2007.05.015.
40. Wang, W., Tang, J., Wei, F., Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol, 2020 Jan 29, 10.1002/jmv.25689 [Epub ahead of print].
41. Kim, J.Y., Choe, P.G., Oh, Y., Oh, K.J., Kim, J., Park, S.J., et al. The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China: implication for infection prevention and control measures. J Korean Med Sci, 35, 2020, e61, 10.3346/jkms.2020.35.e61.
42. World Health Organization (WHO). Novel coronavirus (2019-nCoV). Situation report. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200207-sitrep-18-ncov.pdf?sfvrsn=fa644293_2[accessed 9 February 2020].
43. Patel, A., Jernigan, D.B., 2019-nCoV CDC Response Team. Initial public health response and interim clinical guidance for the 2019 novel coronavirus outbreak—United States, December 31, 2019–February 4, 2020. MMWR Morb Mortal Wkly Rep 69 (2020), 140–146, 10.15585/mmwr.mm6905e1.
44. Casanova, L.M., Jeon, S., Rutala, W.A., Weber, D.J., Sobsey, M.D., Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol 76 (2010), 2712–2717, 10.1128/AEM.02291-09.
45. Kampf, G., Todt, D., Pfaeder, S., Steinmann, E., Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect, 2020 Feb 6, 10.1016/j.jhin.2020.01.022 [Epub ahead of print].
46. Guan, W.J., Ni, Z.Y., Hu, Y., Laing, W.H., Ou, C.Q., He, J.X., et al. Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv, 2020 Feb 9, 10.1101/2020.02.06.20020974.
47. Li, G., Fan, Y., Lai, Y., Han, T., Li, Z., Zhou, P., et al. Coronavirus infections and immune responses. J Med Virol, 2020 Jan 25, 10.1002/jmv.25685 [Epub ahead of print].
48. Russell, C.D., Millar, J.E., Baillie, J.K., Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395 (2020), 473–475, 10.1016/S0140-6736(20)30317-2.